A Prospective Study on Optimizing Treatment for ABPA

NCT05129033 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Allergic Bronchopulmonary Aspergillosis

Interventions

DRUG: Prednisone tablet
DRUG: itraconazole
BIOLOGICAL: Omalizumab

Sponsor

Shanghai Zhongshan Hospital